Langerhans cell histiocytosis
DOI:
https://doi.org/10.23938/ASSN.0365Keywords:
Histiocytosis X. Langerhans cell. Interstitial lung disease.Abstract
We describe the case of male diagnosed with histiocytosis of Langerhans cells. Histiocytosis X is an interstitial disease with a real incidence and an unknown prevalence that can be suspected due to epidemiological and radiological data. The diagnosis can be realized using BAL and/or anatomo-pathological study of a biopsy. The principal treatment is to give up the tobacco habit. Evolution can be favourable.Downloads
References
1. RYU JH, OLSON EJ, MIDTHUN DE, SWENSEN SJ. Diagnostic approach to the patient with diffuse lung disease. Mayo Clin Proc 2002; 77: 1221-1227.
https://doi.org/10.4065/77.11.1221
2. KING TE JR. Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am J Respir Crit Care Med 2005; 172: 268-279.
https://doi.org/10.1164/rccm.200503-483OE
3. BRADLEY B, BRANLEY HM, EGAN JJ, GREAVES MS, HANSELL DM, HARRISON NK et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008; 63 Suppl 5: v1-58.
https://doi.org/10.1136/thx.2008.101691
4. RAGHU G. Interstitial lung disease: a diagnostic approach. Are CT scan and lung biopsy indicated in every patient? Am J Respir Crit Care Med 1995; 151: 909-914.
https://doi.org/10.1164/ajrccm.151.3.7881691
5. KINDER BW, WELLS AU. The art and science of diagnosing interstitial lung diseases. Am J Respir Crit Care Med 2009; 179: 974-975.
https://doi.org/10.1164/rccm.200903-0349ED
6. OHSHIMO S, BONELLA F, CUI A, BEUME M, KOHNO N, GUZMAN J et al. Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009; 179: 1043-1047.
https://doi.org/10.1164/rccm.200808-1313OC
7. GLAZER CS, NEWMAN LS. Occupational interstitial lung disease. Clin Chest Med 2004; 25: 467-468.
https://doi.org/10.1016/j.ccm.2004.04.004
8. PIPAVATH S, GODWIN JD. Imaging of interstitial lung disease. Clin Chest Med 2004; 25: 455-465.
https://doi.org/10.1016/j.ccm.2004.05.008
9. TAZI A. Adult pulmonary Langerhans' cell histiocytosis. Eur Respir J 2006; 27: 1272-1285.
https://doi.org/10.1183/09031936.06.00024004
10. ARICÒ M, GIRSCHIKOFSKY M, GÉNÉREAU T, KLERSY C, MCCLAIN K, GROIS N et al. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer 2003; 39: 2341-2348.
https://doi.org/10.1016/S0959-8049(03)00672-5
11. ALLEN CE, LI L, PETERS TL, LEUNG HC, YU A, MAN TK et al. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. J Immunol 2010; 184: 4557-4567.
https://doi.org/10.4049/jimmunol.0902336
12. ABLA O, EGELER RM, WEITZMAN S. Langerhans cell histiocytosis: Current concepts and treatments. Cancer Treat Rev 2010; 36: 354-359.
https://doi.org/10.1016/j.ctrv.2010.02.012
13. TAZI A, MARC K, DOMINIQUE S, DE BAZELAIRE C, CRESTANI B, CHINET T et al. Serial computed tomography and lung function testing in pulmonary Langerhans' cell histiocytosis. Eur Respir J 2012; 40: 905-912.
https://doi.org/10.1183/09031936.00210711
14. KRAJICEK BJ, RYU JH, HARTMAN TE, LOWE VJ, VASALLO R. Abnormal fluorodeoxyglucose PET in pulmonary Langerhans cell histiocytosis. Chest 2009; 135: 1542-1549.
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
